Another target for ctDNA analysis is the PCNSL tumour-specific MYD88 L265P mutation due to its presence in more than 80% of PCNSL tumours and very rare detection on other non-lymphoma CNS malignancies [31,32,33,34,35]. This evidence concerns the gene MYD88 and lymphoma.